A red zwitterionic co-crystal of acetaminophen and 2,4-pyridinedicarboxylic acid

Journal of Pharmaceutical Sciences

Volumn 99, Issue 9, 2010, Pages 3676-3683

  Sander, John R G ^a   Bučar, Dejan Krešimir ^a   Henry, Rodger F ^b   Baltrusaitis, Jonas ^a,c   Zhang, Geoff G Z ^b   Macgillivray, Leonard R ^a  

^a E11 SSH   (United States)

^b ABBOTT LABORATORIES   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Co crystals; Crystal engineering; Crystal structure; Crystallization; Solid state

Indexed keywords

2,4 PYRIDINEDICARBOXYLIC ACID; AMPHOLYTE; CARBOXYLIC ACID DERIVATIVE; PARACETAMOL; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL STRUCTURE; DENSITY FUNCTIONAL THEORY; DRUG SCREENING; HYDROGEN BOND; MICROSCOPY; X RAY DIFFRACTION;

EID: 77956362007     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22229     Document Type: Article

References (49)

1. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3-26. (Pubitemid 33653411)
2. Qui Y, Chen Y, Zhang GGZ, Liu L, Porter W, editors. 2009. Developing solid oral dosage forms: pharmaceutical theory & practice, 1st edition. Burlington, MA: Academic Press.
3. Bastin RJ, Bowker MJ, Slater BJ. 2000. Salt selection and optimisation procedures for pharmaceutical new chemical entities. Org Proc Res Dev 4:427-435.
4. Gould PL. 1986. Salt selection for basic drugs. Int J Pharm 33:201-217.
5. Haynes DA, Jones W, Motherwell WDS. 2005. Occurrence of pharmaceutically acceptable anions and cations in the Cambridge structural database. J Pharm Sci 94:2111-2120. (Pubitemid 41665273)
6. Serajuddin ATM. 2007. Salt formation to improve drug solubility. Adv Drug Deliv Rev 59:603-616.
7. Stahl PH, Wermuth CG, International Union of Pure and Applied Chemistry. 2002. Handbook of pharmaceutical salts: Properties, selection, and use. 1st edition. Weinheim, NY: VHCA; Wiley-VCH. xiv.
8. Trask AV, Haynes DA, Motherwell WDS, Jones W. 2006. Screening for crystalline salts via mechanochemistry. Chem Commun 51-53.
9. Bernstein J. 2002. Polymorphism in molecular crystals. New York: OxfordClarendon Press, Oxford University Press.
10. Davey RJ. 2003. Pizzas, polymorphs and pills. Chem Commun 1463-1467.
11. Grant DJW, Byrn SR. 2004. A timely re-examination of drug polymorphism in pharmaceutical development and regulation. Adv Drug Deliv Rev 56:237-239.
12. Monissette SL, Almarsson Ö, Peterson ML, Remenar JF, Read MJ, Lemmo AV, Ellis S, Cima MJ, Gardner CR. 2004. High-throughput crystallization: Polymorphs, salts, co-crystals and solvates of phan-naceutical solids. Adv Drug Deliv Rev 56:275-300.
13. Price CP, Grzesiak AL, Matzger AJ. 2005. Crystalline polymorph selection and discovery with polymer heteronuclei. J Am Chem Soc 127:5512-5517.
14. Trask AV, Motherwell WDS, Jones W. 2004. Solvent-drop grinding: Green polymorph control of cocrystallisation. Chem Commun 890-891. (Pubitemid 38530287)
15. Jones W, Motherwell S, Trask AV. 2006. Pharmaceutical cocrystals: An emerging approach to physical property enhancement. MRS Bull 31:875-879.
16. Vishweshwar P, McMahon JA, Bis JA, Zaworotko MJ. 2006. Pharmaceutical co-crystals. J Pharm Sci 95:499-516.
17. Drebushchak TN, Boldyreva EV. 2004. Variable temperature (100-360 K) single-crystal X-ray diffraction study of the orthorhombic polymorph of paracetamol (p-hydroxyacetanilide). Z Kristallogr 219:506-512.
18. Wilson CC. 2000. Variable temperature study of the crystal structure of paracetamol (p-hydroxyacetanilide), by single crystal neutron diffraction. Z Kristallogr 215:693-701.
19. DiMartino P, GuyotHermann AM, Conflant P, Drache M, Guyot JC. 1996. A new pure paracetamol for direct compression: The orthorhombic form. Int J Pharm 128:1-8.
20. Nichols G, Frampton CS. 1998. Physicochemical characterization of the orthorhombic polymorph of paracetamol crystallized from solution. J Pharm Sci 87:684-693.
21. Beyer T, Day GM, Price SL. 2001. The prediction, morphology, and mechanical properties of the polymorphs of paracetamol. J Am Chem Soc 123:5086-5094. (Pubitemid 32905664)
22. Kachrimanis K, Fucke K, Noisternig M, Siebenhaar B, Griesser UJ. 2008. Effects of moisture and residual solvent on the phase stability of orthorhombic paracetamol. Pharm Res 25:1440-1449.
23. Oswald IDH, Allan DR, McGregor PA, Motherwell WDS, Parsons S, Pulham CR. 2002. The formation of paracetamol (acetaminophen) adducts with hydrogen-bond acceptors. Acta Crystallogr B 58:1057-1066.
24. Childs SL, Stahly GP, Park A. 2007. The salt-cocrystal continuum: The influence of crystal structure on ionization state. Mol Pharmaceut 4:323-338.
25. Karki S, Friscic T, Fabian L, Laity PR, Day GM, Jones W. 2009. Improving mechanical properties of crystalline solids by cocrystal formation: new compressible forms of paracetamol. Adv Mater 21:3905-3909.
26. Liang P. 2008. A cocrystal of pyridine-2,4-dicarboxylic acid and serine. Acta Crystallogr E 64:O43/1-O43/7.
27. Allen FH. The Cambridge Structural Database: a quarter of a million crystal structures and rising. Acta Crystallogr B 58:380-388.
28. Bruno IJ, Cole JC, Edgington PR, Kessler M, Macrae CF, McCabe P, Pearson J, Taylor R. 2002. New software for searching the Cambridge Structural Database and visualizing crystal structures. Acta Crystallogr B 58:389-397.
29. A literature search revealed three additional cocrystals. CCDC reference codes: 720356, 720366 and 720368.
30. Zhang GGZ, Henry RF, Borchardt TB, Lou XC. 2007. Efficient co-crystal screening using solution-mediated phase transformation. J Pharm Sci 96:990-995.
31. Sonicator bath: Branson 2510R-DTM(frequency: 42 kHz (6% at 100 W)).
32. Symphonix; Inel Corp.: Artenay, France.
33. Jade 6.5; Materials Data, Inc.: Livermore, CA, 2002.
34. 1997-2003. SAINT-Plus. 6.45 ed., Madison, WI, USA Bruker AXS Inc.
35. 2004. XSHELL. v6.3.1ed., Madison, WI, USA: Bruker AXS Inc.
36. Dovesi R, Saunders VR, Roetti C, Orlando R, Zicovich-Wilson CM, Pascale F, Civalleri B, Doll K, Harrison NM, Bush IJ, D'Arco P, Llunell M. 2006. OT CRYSTAL'06. User's Manual; University of Torino: Torino.
37. Perdew JP, Burke K, Ernzerhof M. 1996. Generalized gradient approximation made simple. Phys Rev Lett 77:3865. (Pubitemid 126631804)
38. Haisa M, Kashino S, Kawai R, Maeda H. 1976. The monoclinic form of p-hydroxyacetanilide. Acta Crystallogr B B32:1283-1285.
39. Becke AD. 1993. Density-functional thermochemistry. III. The role of exact exchange. J Chem Phys 98:5648-5652.
40. Lee C, Yang W, Parr RG. 1988. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B 37:785.
41. Searle BG. 2001. DL visualize. Comput Phys Commun 137:25-32.
42. Calculated values were obtained from the Sci-Finder Scholar database (version 2007) calculated using Advanced Chemistry Development (ACD/Labs) Software (version 8.14) for Solaris (copyright 1994-2010 ACD/Labs).
43. Calculated band gap indicates the cocrystal should behave as a semiconductor(see: references 42 and 43).
44. Brütting W, editor. 2005. Physics of organic semiconductors, 1st edition. Weinheim, Germany: Wiley-VCH.
45. Hench LL, West JK. 1990. Principles of electronic ceramics, 1st edition. New York: Wiley.
46. Lynch DE, Smith G, Byriel KA, Kennard CHL. 1998. Designing linear hydrogen-bonded arrays by using substituted charge-transfer complexes. The crystal structure of the 1: 1 adduct of indole-2-carboxylic acid with 3,5-dinitrobenzoic acid. Aust J Chem 51:1019-1024.
47. Sharma CVK, Panneerselvam K, Pilati T, Desiraju GR. 1993. Molecular recognition involving an interplay of O-H···O, C-H···O, and π···π-interactions. The anomalous crystal-structure of the 1:1 complex 3,5-dinitrobenzoic acid-4-(N,N-dimethylamino) benzoic acid. J Chem Soc Perk T 2:2209-2216.
48. Aakeröy CB, Beatty AM, Helfrich BA. 2001. "Total synthesis" supramolecular style: Design and hydrogen-bond-directed assembly of ternary supermolecules. Angew Chem Int Ed 40:3240-3242.
49. Aakeröy CB, Bahra GS, Brown CR, Hitchcock PB, Patell Y, Seddon KR. 1995. L-proline 2,5-dihydroxybenzoic acid (1/1): A zwitterion co-crystal. Acta Chem Scand 49:762-767.